Study: Nanoparticle vaccines enhance cross-protection against influenza viruses
2024-07-10
(Press-News.org)
ATLANTA — To offer cross-protection against diverse influenza virus variants, nanoparticle vaccines can produce pivotal cellular and mucosal immune responses that enhance vaccine efficacy and broaden protection, according to a study by researchers in the Institute for Biomedical Sciences at Georgia State University.
The study, published in the journal Nature Communications, offers valuable insights into tailoring immunization strategies to optimize influenza vaccine effectiveness. To alleviate the significant public health burden of influenza epidemics and occasional pandemics, it’s essential to enhance influenza vaccine cross-protection, according to the authors.
While the Centers for Disease Control and Prevention (CDC) recommends annual influenza vaccination, current seasonal influenza vaccines typically provide strain-specific and short-lived immunity. Seasonal influenza vaccines offer limited cross-protection against antigenically diverse virus variants and provide no defense against sporadic influenza pandemics, the authors explained.
“Developing effective influenza vaccines or vaccination strategies that can confer cross-protection against variant influenza viruses is a high priority to mitigate the public health consequences of influenza,” said Dr. Chunhong Dong, first author of the study and a postdoctoral fellow in the Institute for Biomedical Sciences at Georgia State.
In the study, the researchers investigated the effects of immunization strategies on the generation of cross-protective immune responses in female mice using mRNA lipid nanoparticle (LNP) and protein-based polyethyleneimine-HA/CpG (PHC) nanoparticle vaccines targeting influenza hemagglutinin. The mice were immunized with either intramuscular mRNA LNP or intranasal PHC vaccines in a typical prime-plus-boost regimen. A variety of sequential immunization strategies were included in this study for parallel comparison.
“We demonstrated that cellular and mucosal immune responses are pivotal correlates of cross-protection against influenza,” said Dr. Baozhong Wang, senior author of the study and a Distinguished University Professor in the Institute for Biomedical Sciences at Georgia State. “Notably, intranasal PHC immunization outperforms its intramuscular counterpart in inducing mucosal immunity and conferring cross-protection. Sequential mRNA LNP prime and intranasal PHC boost demonstrated optimal cross-protection against antigenically drifted and shifted influenza strains.”
The study highlights the importance of immunization orders and indicates that in a sequential immunization, an mRNA vaccine priming plays an important role in steering the Th1/Th2 immune responses. Also, the intranasal PHC boost is crucial to the induction of mucosal immunity, Wang said.
Additional authors of the study include Wandi Zhu, Lai Wei, Joo Kyung Kim, Yao Ma and Sang-Moo Kang of the Institute for Biomedical Sciences at Georgia State.
The study is funded by the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases (NIAID).
To read the study, visit https://www.nature.com/articles/s41467-024-50087-5.
END
ELSE PRESS RELEASES FROM THIS DATE:
2024-07-10
URBANA, Ill. – Colleges and universities often highlight leadership development as a critical component of their curriculum — but there is no clear consensus on what constitutes effective leadership education. In a new paper, two educators from the University of Illinois Urbana-Champaign and John Carroll University provide a roadmap for training competent leaders, suggesting a comprehensive, practical approach for postsecondary institutions to follow.
“Our purpose was to discuss what it means to develop leaders and what a model for leadership education could ...
2024-07-10
The question of whether Mars ever supported life has captivated the imagination of scientists and the public for decades. Central to the discovery is gaining insight into the past climate of Earth’s neighbor: was the planet warm and wet, with seas and rivers much like those found on our own planet? Or was it frigid and icy, and therefore potentially less prone to supporting life as we know it? A new study finds evidence to support the latter by identifying similarities between soils found on Mars and those of Canada’s Newfoundland, a cold subarctic climate.
The study, published July 7th in Communications Earth and Environment, looked for soils on Earth with ...
2024-07-10
Taylor Swift’s past struggles with body image, disordered eating, and body objectification have had an overall positive influence on her fans’ attitudes on these issues, a new study from University of Vermont (UVM) researchers finds.
The new research, published in journal Social Science & Medicine, analyzed the top 200 TikTok and Reddit posts—including over 8,300 online comments—about Taylor Swift, eating disorders, and body image to determine the impact of Swift’s disclosures about her past eating disorder on her fans.
“Our findings suggest that fans who felt highly connected to Swift were influenced to positively change their behaviors ...
2024-07-10
Cystic fibrosis is one of the most common genetic disorders, causing thick mucus build-up in the lungs and other parts of the body, breathing problems, and infection. A three-drug cocktail known as Trikafta has greatly improved patient quality of life since its development in 2019, but can cause cataracts and liver damage and must be taken daily at a cost of about $300,000 per year.
Now, researchers at the Broad Institute of MIT and Harvard and the University of Iowa have developed a gene-editing approach that efficiently corrects the most common mutation that causes cystic fibrosis, found in 85 percent of patients. With further development, it could ...
2024-07-10
Researchers have identified unique 3-dimensional features called TULIPs in the genome of posterior fossa group A (PFA) ependymoma, a difficult-to-treat brain tumor diagnosed in very young children. The findings, published in Cell by a team of researchers at Baylor College of Medicine, Texas Children’s Hospital, McGill University and collaborating institutions, could lead to the development of new treatments.
“PFA ependymomas are lethal. Radiation therapy, the only treatment currently available, is not curative and can cause serious developmental and cognitive issues,” ...
2024-07-10
While taking snapshots with the high-speed “electron camera” at the Department of Energy’s SLAC National Acceleratory Laboratory, researchers discovered new behavior in an ultrathin material that offers a promising approach to manipulating light that will be useful for devices that detect, control or emit light, collectively known as optoelectronic devices, and investigating how light is polarized within a material. Optoelectronic devices are used in many technologies that touch our daily lives, including ...
2024-07-10
WASHINGTON, DC – Applications are currently being accepted for the Spring 2025 term of two programs offered by the Department of Energy (DOE) Office of Science (SC): the Science Undergraduate Laboratory Internships (SULI) program and the Community College Internships (CCI) program. The application deadline for the two programs is 5:00 pm (ET) October 2, 2024.
Through the SULI and CCI programs, undergraduate students and recent graduates discover science and technology careers at the DOE national laboratories and gain the experience ...
2024-07-10
Toronto, ON – In a groundbreaking effort to mitigate the risks associated with muscle-building dietary supplement use among adolescents and young adults, a comprehensive set of guidelines has been introduced to assist healthcare professionals. These guidelines, published in the Journal of Adolescent Health, focus on assessment and harm reduction strategies to better support young individuals engaged in the use of these readily available supplements.
Muscle-building dietary supplements, such as whey protein and creatine monohydrate, are commonly used by adolescents and young adults, particularly boys and young men, and are intended to enhance muscle mass, ...
2024-07-10
Amsterdam UMC's Alzheimer Centre has developed a prediction model that can predict cognitive decline in patients with mild cognitive impairment or mild dementia due to Alzheimer's disease. The next step is developing an app that uses this prediction model, which would represent an important step towards personalised forecasts for patients. The study is published today in the journal Neurology.
After people have been diagnosed with Alzheimer's, their first question is often: "What can I expect now?". This question is difficult ...
2024-07-10
MINNEAPOLIS – A new study looks at predicting how quickly people with early Alzheimer’s disease will experience cognitive decline. The study is published in the July 10, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. It also looked at how the new drugs recently approved for the disease may reduce decline.
“The rate of cognitive decline varies greatly from person to person, and people are very interested in what to expect from the disease in themselves or their loved ones, so better prediction models are urgently needed,” said study author Pieter J. van der Veere, M.D., of Amsterdam ...
LAST 30 PRESS RELEASES:
[Press-News.org] Study: Nanoparticle vaccines enhance cross-protection against influenza viruses
